|
| Premarket roundup: Baxter, Bristol-Myers Squibb |
6 May 08, 14:02 |
|
| Despite a first quarter in which Baxter International Inc. had to recall its blood thinner heparin amid a Food and Drug Administration investigation into contamination of the product, analysts say the company is poised for growth. |
| more |
|
